Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
q5sgyXSRMRmzS6ef